Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Antivirals underutilized after curative resection of HBV- or HCV-related HCC
Antiviral therapy is associated with substantial improvements in long-term overall survival (OS) but severely underutilized after curative hepatic resection in patients with hepatitis B virus (HBV)– or hepatitis C virus (HCV)–related hepatocellular carcinoma (HCC), a real-world study involving predominantly Asian patients has shown.
Antivirals underutilized after curative resection of HBV- or HCV-related HCC
15 Jan 2024
AFP-L3, DCP predict HCC recurrence after liver transplant
Dual positivity for alpha-fetoprotein (AFP) bound to Lens culinaris agglutinin (AFP-L3) ≥15 percent and des-gamma-carboxyprothrombin (DCP) ≥7.5 can strongly predict majority of early hepatocellular carcinoma (HCC) recurrences following liver transplantation (LT), suggests a study.
AFP-L3, DCP predict HCC recurrence after liver transplant
13 Dec 2023
Molecular-based guided therapy shows promise in treatment-resistant HCC/H-CCK
A recent study has demonstrated the feasibility of molecular-based targeted therapy in patients with hepatocellular carcinoma (HCC)/hepato-cholangiocarcinoma (H-CCK) that progressed while under treatment with atezolizumab/bevacizumab.